BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10828042)

  • 21. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease.
    Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K
    Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Report of a new mutation in CYBB gene in two patients with X linked chronic granulomatous disease].
    Agudelo-Flórez P; Navarro S; Luttges P; López JA; Norambuena X; Navarrete S CL; Quezada A; Spencer M; Condino-Neto A; Cornejo de M
    Rev Med Chil; 2006 Aug; 134(8):965-72. PubMed ID: 17130983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel polymorphism in the coding region of CYBB, the human gp91-phox gene.
    Kuribayashi F; de Boer M; Leusen JH; Verhoeven AJ; Roos D
    Hum Genet; 1996 May; 97(5):611-3. PubMed ID: 8655140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression.
    Sokolic RA; Sekhsaria S; Sugimoto Y; Whiting-Theobald N; Linton GF; Li F; Gottesman MM; Malech HL
    Blood; 1996 Jan; 87(1):42-50. PubMed ID: 8547675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splice site mutations are a common cause of X-linked chronic granulomatous disease.
    de Boer M; Bolscher BG; Dinauer MC; Orkin SH; Smith CI; Ahlin A; Weening RS; Roos D
    Blood; 1992 Sep; 80(6):1553-8. PubMed ID: 1520880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematologically important mutations: X-linked chronic granulomatous disease (third update).
    Roos D; Kuhns DB; Maddalena A; Roesler J; Lopez JA; Ariga T; Avcin T; de Boer M; Bustamante J; Condino-Neto A; Di Matteo G; He J; Hill HR; Holland SM; Kannengiesser C; Köker MY; Kondratenko I; van Leeuwen K; Malech HL; Marodi L; Nunoi H; Stasia MJ; Ventura AM; Witwer CT; Wolach B; Gallin JI
    Blood Cells Mol Dis; 2010 Oct; 45(3):246-65. PubMed ID: 20729109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De Novo Somatic Mosaicism of CYBB Caused by Intronic LINE-1 Element Insertion Resulting in Chronic Granulomatous Disease.
    Yu L; Li W; Lv G; Sun G; Yang L; Chen J; Zhou L; Ding Y; Zhang Z; Tang X; An Y; Zhao X
    J Clin Immunol; 2023 Jan; 43(1):88-100. PubMed ID: 35997928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel missense mutation in the NADPH binding domain of CYBB abolishes the NADPH oxidase activity in a male patient with increased susceptibility to infections.
    Khan TA; Kalsoom K; Iqbal A; Asif H; Rahman H; Farooq SO; Naveed H; Nasir U; Amin MU; Hussain M; Tipu HN; Florea A
    Microb Pathog; 2016 Nov; 100():163-169. PubMed ID: 27666509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of a novel splice site mutation within the CYBB gene leading to X-linked chronic granulomatous disease.
    Barese CN; Copelli SB; De Matteo E; Zandomeni R; Salgueiro F; Di Giovanni D; Heyworth P; Rivas EM
    Pediatr Blood Cancer; 2005 Apr; 44(4):420-2. PubMed ID: 15468310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel mutations in CYBB Gene Cause X-linked chronic Granulomatous Disease in Pakistani patients.
    Gul I; Khan TA; Akbar NU; Gul N; Ali R; Khan SN
    Ital J Pediatr; 2023 Aug; 49(1):95. PubMed ID: 37533075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.
    Weening RS; De Boer M; Kuijpers TW; Neefjes VM; Hack WW; Roos D
    Clin Exp Immunol; 2000 Dec; 122(3):410-7. PubMed ID: 11122248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of cryptic splice sites in three patients with chronic granulomatous disease.
    de Boer M; van Leeuwen K; Hauri-Hohl M; Roos D
    Mol Genet Genomic Med; 2019 Sep; 7(9):e854. PubMed ID: 31364312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential role of nuclear factor-kappaB for NADPH oxidase activity in normal and anhidrotic ectodermal dysplasia leukocytes.
    Luengo-Blanco M; Prando C; Bustamante J; Aragão-Filho WC; Pereira PV; Rehder J; Padden C; Casanova JL; Newburger PE; Condino-Neto A
    Blood; 2008 Aug; 112(4):1453-60. PubMed ID: 18523147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A second case of somatic triple mosaicism in the CYBB gene causing chronic granulomatous disease.
    Noack D; Heyworth PG; Kyono W; Cross AR
    Hum Genet; 2001 Aug; 109(2):234-8. PubMed ID: 11511930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
    Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
    J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity.
    Jendrossek V; Ritzel A; Neubauer B; Heyden S; Gahr M
    Eur J Haematol; 1997 Feb; 58(2):78-85. PubMed ID: 9111587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unusual late presentation of X-linked chronic granulomatous disease in an adult female with a somatic mosaic for a novel mutation in CYBB.
    Wolach B; Scharf Y; Gavrieli R; de Boer M; Roos D
    Blood; 2005 Jan; 105(1):61-6. PubMed ID: 15308575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.
    Wolach B; Broides A; Zeeli T; Gavrieli R; de Boer M; van Leeuwen K; Levy J; Roos D
    J Clin Immunol; 2011 Aug; 31(4):560-6. PubMed ID: 21604087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the IFN-gamma-induced enhancement of superoxide production in CGD-phagocytes caused by increased expression of the p47-phox cytosolic protein.
    Jendrossek V; Damm U; Liese J; Belohradsky BH; Gahr M
    Immunodeficiency; 1993; 4(1-4):187-90. PubMed ID: 8167697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation.
    Anderson-Cohen M; Holland SM; Kuhns DB; Fleisher TA; Ding L; Brenner S; Malech HL; Roesler J
    Clin Immunol; 2003 Dec; 109(3):308-17. PubMed ID: 14697745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.